Ascent Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.01M | Sell |
21,621
-2,955
| -12% | -$548K | 0.16% | 135 |
|
|
2025
Q1 | $5.15M | Sell |
24,576
-1,360
| -5% | -$285K | 0.22% | 97 |
|
|
2024
Q4 | $4.61M | Buy |
25,936
+1,389
| +6% | +$247K | 0.35% | 69 |
|
|
2024
Q3 | $4.85M | Sell |
24,547
-1,231
| -5% | -$243K | 0.37% | 62 |
|
|
2024
Q2 | $4.42M | Buy |
25,778
+1,102
| +4% | +$189K | 0.36% | 64 |
|
|
2024
Q1 | $4.49M | Buy |
24,676
+7,787
| +46% | +$1.42M | 0.4% | 55 |
|
|
2023
Q4 | $2.92M | Buy |
16,889
+1,819
| +12% | +$315K | 0.28% | 90 |
|
|
2023
Q3 | $2.08M | Sell |
15,070
-7,787
| -34% | -$1.07M | 0.23% | 123 |
|
|
2023
Q2 | $3.42M | Buy |
22,857
+1,257
| +6% | +$188K | 0.38% | 64 |
|
|
2023
Q1 | $3.44M | Buy |
21,600
+11,667
| +117% | +$1.86M | 0.37% | 64 |
|
|
2022
Q4 | $1.61M | Buy |
9,933
+973
| +11% | +$157K | 0.19% | 163 |
|
|
2022
Q3 | $1.31M | Buy |
8,960
+4,780
| +114% | +$700K | 0.16% | 177 |
|
|
2022
Q2 | $600K | Buy |
4,180
+949
| +29% | +$136K | 0.07% | 269 |
|
|
2022
Q1 | $524K | Buy |
3,231
+246
| +8% | +$39.9K | 0.06% | 293 |
|
|
2021
Q4 | $394K | Buy |
+2,985
| New | +$394K | 0.05% | 339 |
|